Measuring the in situ activation status of T cells is important to gauge the efficacy of immunotherapy approaches. In this Article the authors design a chemical probe that binds to the T cell membrane and scavenges reactive oxygen species (ROS), preventing ROS-driven T cell exhaustion while serving as a magnetic resonance imaging probe to quantify T cell activity in tumours and predict radiotherapy outcomes.
- Changrong Shi
- Qianyu Zhang
- Zijian Zhou
